Jason Bruce Williams, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphocytes, Tumor-Infiltrating | 5 | 2020 | 1090 | 0.810 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2017 | 25 | 0.570 |
Why?
|
| Tumor Microenvironment | 5 | 2020 | 3826 | 0.550 |
Why?
|
| Genetic Heterogeneity | 1 | 2020 | 724 | 0.540 |
Why?
|
| Interferon-gamma | 3 | 2020 | 3160 | 0.470 |
Why?
|
| Immunologic Memory | 1 | 2020 | 1354 | 0.430 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2020 | 4554 | 0.350 |
Why?
|
| Antigens, Neoplasm | 2 | 2017 | 1999 | 0.340 |
Why?
|
| T-Lymphocytes | 4 | 2020 | 10183 | 0.270 |
Why?
|
| Antigens, CD | 1 | 2017 | 4002 | 0.270 |
Why?
|
| Neoplasms | 4 | 2020 | 22066 | 0.210 |
Why?
|
| Melanoma, Experimental | 2 | 2022 | 562 | 0.190 |
Why?
|
| T-Lymphocytes, Regulatory | 4 | 2019 | 3076 | 0.180 |
Why?
|
| Clone Cells | 2 | 2022 | 1663 | 0.170 |
Why?
|
| Signal Transduction | 3 | 2020 | 23363 | 0.170 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2019 | 20 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 698 | 0.140 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2017 | 1811 | 0.140 |
Why?
|
| T-Cell Antigen Receptor Specificity | 2 | 2017 | 85 | 0.130 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2020 | 1351 | 0.130 |
Why?
|
| Immunomodulation | 1 | 2020 | 547 | 0.130 |
Why?
|
| Immune Tolerance | 4 | 2019 | 2299 | 0.130 |
Why?
|
| Mutation | 2 | 2020 | 29950 | 0.130 |
Why?
|
| Bifidobacterium | 1 | 2015 | 98 | 0.120 |
Why?
|
| Neoplasms, Experimental | 1 | 2020 | 1229 | 0.120 |
Why?
|
| Thymus Gland | 1 | 2019 | 1246 | 0.110 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 9531 | 0.110 |
Why?
|
| Transplantation Tolerance | 1 | 2018 | 605 | 0.110 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2019 | 825 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2012 | 2536 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 22025 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 3 | 2022 | 9196 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 3 | 2019 | 1613 | 0.100 |
Why?
|
| Inflammasomes | 1 | 2016 | 532 | 0.090 |
Why?
|
| Interleukin-2 | 1 | 2017 | 1890 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 16905 | 0.080 |
Why?
|
| Colitis | 2 | 2019 | 1229 | 0.080 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2012 | 825 | 0.080 |
Why?
|
| Mice | 11 | 2022 | 81216 | 0.070 |
Why?
|
| Animals | 12 | 2022 | 167940 | 0.070 |
Why?
|
| Interleukin-10 | 1 | 2012 | 1174 | 0.070 |
Why?
|
| Graft Rejection | 1 | 2018 | 4423 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10434 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2019 | 11480 | 0.060 |
Why?
|
| DNA | 1 | 2016 | 7236 | 0.050 |
Why?
|
| Mice, Knockout | 4 | 2017 | 14396 | 0.040 |
Why?
|
| Freund's Adjuvant | 1 | 2019 | 149 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2016 | 7854 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2019 | 220 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 9590 | 0.040 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2019 | 305 | 0.040 |
Why?
|
| Melanoma | 1 | 2015 | 5695 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2012 | 2671 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 5797 | 0.030 |
Why?
|
| Caspase 1 | 1 | 2016 | 226 | 0.030 |
Why?
|
| Autoantigens | 1 | 2019 | 877 | 0.030 |
Why?
|
| Nucleotidyltransferases | 1 | 2016 | 244 | 0.030 |
Why?
|
| Symbiosis | 1 | 2015 | 293 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 18134 | 0.030 |
Why?
|
| Mice, Inbred AKR | 1 | 2012 | 104 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2012 | 6226 | 0.030 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2012 | 111 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 2016 | 967 | 0.030 |
Why?
|
| Humans | 7 | 2022 | 760261 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2015 | 1006 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2012 | 652 | 0.020 |
Why?
|
| Immunity | 1 | 2015 | 998 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2011 | 602 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2012 | 801 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2011 | 825 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 1760 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2019 | 1905 | 0.020 |
Why?
|
| DNA Damage | 1 | 2017 | 2442 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3758 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2019 | 5120 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2012 | 18968 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 2805 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 5498 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2015 | 2730 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2012 | 3735 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2011 | 1370 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9388 | 0.010 |
Why?
|
| Apoptosis | 1 | 2017 | 9497 | 0.010 |
Why?
|
| Macrophages | 1 | 2016 | 5745 | 0.010 |
Why?
|
| Female | 2 | 2017 | 391011 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13505 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2015 | 4637 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 2421 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 11902 | 0.010 |
Why?
|
| Inflammation | 1 | 2011 | 10757 | 0.010 |
Why?
|